Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert P Gale

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Advances in Cell and Gene Therapy|August 25, 2020
Perspective: Cell therapy, SARS-CoV-2, COVID-19, and James LindRobert P Gale
British Journal of Haematology|June 2, 2020
Conquest of COVID-19. Publish it to death?Robert P Gale
British Journal of Haematology|February 15, 2020
Prospects for achieving treatment-free remission in chronic myeloid leukaemiaGiuseppe Saglio, Robert P Gale
Haematologica|January 2, 2025
Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the PROSEdward Copelan, Robert P Gale
The New England Journal of Medicine|May 3, 2023
Zanubrutinib in Chronic Lymphocytic LeukemiaYang Liang, Robert P Gale
Bone Marrow Transplantation|November 25, 2025
Hematopoietic cell transplantation in first relapse of (CBF- and other) AMLEdward A Copelan, Robert P Gale
The New England Journal of Medicine|June 21, 2018
Are We Prepared for Nuclear Terrorism?Robert P Gale, James O Armitage
The New England Journal of Medicine|March 29, 2018
Are We Prepared for Nuclear Terrorism?Robert P Gale, James O Armitage
The New England Journal of Medicine|August 11, 2016
Assessment of Minimal Residual Disease in Standard-Risk AMLMegan Othus, Elihu Estey, Robert P Gale
Ejhaem|April 10, 2026
Are Myeloproliferative Neoplasms-Unclassifiable Really Unclassifiable?Giovanni Barosi, Vittorio Rosti, Robert P Gale
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Advances in Cell and Gene Therapy|August 25, 2020
Perspective: Cell therapy, SARS-CoV-2, COVID-19, and James LindRobert P Gale
British Journal of Haematology|June 2, 2020
Conquest of COVID-19. Publish it to death?Robert P Gale
British Journal of Haematology|February 15, 2020
Prospects for achieving treatment-free remission in chronic myeloid leukaemiaGiuseppe Saglio, Robert P Gale
Haematologica|January 2, 2025
Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the PROSEdward Copelan, Robert P Gale
The New England Journal of Medicine|May 3, 2023
Zanubrutinib in Chronic Lymphocytic LeukemiaYang Liang, Robert P Gale
Bone Marrow Transplantation|November 25, 2025
Hematopoietic cell transplantation in first relapse of (CBF- and other) AMLEdward A Copelan, Robert P Gale
The New England Journal of Medicine|June 21, 2018
Are We Prepared for Nuclear Terrorism?Robert P Gale, James O Armitage
The New England Journal of Medicine|March 29, 2018
Are We Prepared for Nuclear Terrorism?Robert P Gale, James O Armitage
The New England Journal of Medicine|August 11, 2016
Assessment of Minimal Residual Disease in Standard-Risk AMLMegan Othus, Elihu Estey, Robert P Gale
Ejhaem|April 10, 2026
Are Myeloproliferative Neoplasms-Unclassifiable Really Unclassifiable?Giovanni Barosi, Vittorio Rosti, Robert P Gale
Pageof 5